Pcp43 - Health Impact Modelling (Him): Concept, Approach and Real-World Data Needs for the Estimation of Potential Effectiveness Provided by a Pharma Company Portfolio

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.518
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Availability and Consistency of Dengue Surveillance Data Provided Online by the World Health Organization

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2015English

Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Pipeline Analysis of a Vaccine Candidate Portfolio for Diseases of Poverty Using the Portfolio-To-Impact Modelling Tool

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2020English

Funding Global Health Product R&D: The Portfolio-To-Impact Model (P2I), a New Tool for Modelling the Impact of Different Research Portfolios

Gates Open Research
GeneticsMolecular BiologyEnvironmentalBiochemistryPublic HealthMicrobiology Health PolicyMedicineImmunologyOccupational Health
2018English

Multi-Portfolio Optimization: A Potential Game Approach

Lecture Notes of the Institute for Computer Sciences, Social-Informatics and Telecommunications Engineering
Computer NetworksCommunications
2012English

Real-World Data Utility for Health Economic Modeling: An Assessment of Current Data Sources

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Developing a Novel Grey Integrated Multi-Criteria Approach for Enhancing the Supplier Selection Procedure: A Real-World Case of Textile Company

Decision Science Letters
Decision Sciences
2019English

Less Biased Estimation of the Survival Benefit of Carotid Endarterectomy Using Real-World Data

JAMA network open
Medicine
2018English

Limited Data to Evaluate Real‐World Effectiveness of Enzyme Replacement Therapy for Mucopolysaccharidosis Type I

Journal of Inherited Metabolic Disease
Genetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy